PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40632978,Consistency and Heterogeneity of Microsatellite Instability (MSI) Status in Paired Biopsy and Surgical Specimens of Colorectal Cancer: A Necessity for MSI Reassessment After Treatment?,2025,Linghua Yan; Baoye Wei; Fei Liu,"Shanghai Tongshu Biotech Co Ltd, Shanghai, China.",N/A
40632867,Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.,2025,Molly A Bingham; Julius R Herzog; Abigail Wong-Rolle; Meghali Goswami; Jason Reeves; Sean Kim; Arya Bahrami; Hermann F Degenhardt; George Zaki; Prajan Divakar; Chen Zhao,"Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD, USA.; NanoString Technologies Inc., Seattle, WA, USA.; Thoracic and GI Malignancies Branch, CCR, NCI, Bethesda, MD, USA.; Biomedical Informatics and Data Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.",N/A
40632607,Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201.,2025,Steven M Devine,"Be the Match Foundation, Minneapolis, MN, USA.",N/A
40632497,Deciphering the MHC immunopeptidome of human cancers with Ligand.MHC atlas.,2025,Meilin Mu; Shengbao Suo,"Guangzhou National Laboratory, Guangzhou 510005, China.",N/A
40632461,Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.,2025,Zakile A Mfumbilwa; Janneke A Wilschut; Veerle M H Coup√©,"Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands. v.coupe@amsterdamumc.nl.",v.coupe@amsterdamumc.nl
